Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2019 Jun 14

PMID 31191296

Citations 34

Authors

Vijayasree V Giridharan

Faisal Masud

Fabricia Petronilho

Felipe Dal-Pizzol

Tatiana Barichello

Affiliations

Soon will be listed here.

Citing Articles

Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.

Al-Abbas N, Shaer N J Alzheimers Dis Rep. 2025; 8(1):1705-1721.

PMID: 40034366 PMC: 11863740. DOI: 10.1177/25424823241309024.

Cell-specific transcriptional signatures of vascular cells in Alzheimer's disease: perspectives, pathways, and therapeutic directions.

Chaudhuri S, Cho M, Stumpff J, Bice P, Is O, Ertekin-Taner N Mol Neurodegener. 2025; 20(1):12.

PMID: 39876020 PMC: 11776188. DOI: 10.1186/s13024-025-00798-0.

Chronic obstructive pulmonary disease as a risk factor for cognitive impairment: a systematic review and meta-analysis.

Chen X, Yu Z, Liu Y, Zhao Y, Li S, Wang L BMJ Open Respir Res. 2024; 11(1).

PMID: 39608869 PMC: 11603807. DOI: 10.1136/bmjresp-2023-001709.

Alzheimer's Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-β Production.

Wei S, Ma X, Chen Y, Wang J, Hu L, Liu Z Mol Neurobiol. 2024; 62(4):5109-5132.

PMID: 39514171 DOI: 10.1007/s12035-024-04579-6.

Prevalence of Antibiotic Resistance in Older Adults and Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.

Gohil N, Gandara F, Gohil H, Gurajala S, Innocent D, Tesfaye T J Alzheimers Dis Rep. 2024; 8(1):1241-1251.

PMID: 39434821 PMC: 11491939. DOI: 10.3233/ADR-240057.

References

McGeer P, McGeer E, Yasojima K . Alzheimer disease and neuroinflammation. J Neural Transm Suppl. 2000; 59:53-7. DOI: 10.1007/978-3-7091-6781-6_8. View

Rock R, Gekker G, Hu S, Sheng W, Cheeran M, Lokensgard J . Role of microglia in central nervous system infections. Clin Microbiol Rev. 2004; 17(4):942-64, table of contents. PMC: 523558. DOI: 10.1128/CMR.17.4.942-964.2004. View

Kuo H, Yen C, Chang C, Kuo C, Chen J, Sorond F . Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005; 4(6):371-80. DOI: 10.1016/S1474-4422(05)70099-5. View

Balin B, Little C, Hammond C, Appelt D, Whittum-Hudson J, Gerard H . Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis. 2008; 13(4):371-80. DOI: 10.3233/jad-2008-13403. View

Kamer A, Dasanayake A, Craig R, Glodzik-Sobanska L, Bry M, de Leon M . Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis. 2008; 13(4):437-49. DOI: 10.3233/jad-2008-13408. View

Semmler A, Hermann S, Mormann F, Weberpals M, Paxian S, Okulla T . Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008; 5:38. PMC: 2553764. DOI: 10.1186/1742-2094-5-38. View

Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S . Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009; 73(10):768-74. PMC: 2848584. DOI: 10.1212/WNL.0b013e3181b6bb95. View

Soscia S, Kirby J, Washicosky K, Tucker S, Ingelsson M, Hyman B . The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010; 5(3):e9505. PMC: 2831066. DOI: 10.1371/journal.pone.0009505. View

Iwashyna T, Wesley Ely E, Smith D, Langa K . Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010; 304(16):1787-94. PMC: 3345288. DOI: 10.1001/jama.2010.1553. View

10.

Miklossy J . Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med. 2011; 13:e30. DOI: 10.1017/S1462399411002006. View

11.

Linnartz B, Neumann H . Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia. 2012; 61(1):37-46. DOI: 10.1002/glia.22359. View

12.

Krstic D, Knuesel I . Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2012; 9(1):25-34. DOI: 10.1038/nrneurol.2012.236. View

13.

Chhor V, Le Charpentier T, Lebon S, Ore M, Celador I, Josserand J . Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun. 2013; 32:70-85. PMC: 3694309. DOI: 10.1016/j.bbi.2013.02.005. View

14.

Bu X, Yao X, Jiao S, Zeng F, Liu Y, Xiang Y . A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol. 2014; 22(12):1519-25. DOI: 10.1111/ene.12477. View

15.

Tycko R . Amyloid polymorphism: structural basis and neurobiological relevance. Neuron. 2015; 86(3):632-45. PMC: 4425266. DOI: 10.1016/j.neuron.2015.03.017. View

16.

Abbayya K, Puthanakar N, Naduwinmani S, Chidambar Y . Association between Periodontitis and Alzheimer's Disease. N Am J Med Sci. 2015; 7(6):241-6. PMC: 4488989. DOI: 10.4103/1947-2714.159325. View

17.

Itzhaki R, Lathe R, Balin B, Ball M, Bearer E, Braak H . Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016; 51(4):979-84. PMC: 5457904. DOI: 10.3233/JAD-160152. View

18.

Masters C, Bateman R, Blennow K, Rowe C, Sperling R, Cummings J . Alzheimer's disease. Nat Rev Dis Primers. 2016; 1:15056. DOI: 10.1038/nrdp.2015.56. View

19.

Kumar D, Choi S, Washicosky K, Eimer W, Tucker S, Ghofrani J . Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med. 2016; 8(340):340ra72. PMC: 5505565. DOI: 10.1126/scitranslmed.aaf1059. View

20.

Golde T . Alzheimer disease: Host immune defence, amyloid-β peptide and Alzheimer disease. Nat Rev Neurol. 2016; 12(8):433-4. DOI: 10.1038/nrneurol.2016.105. View